O Dr. Alemdar é especializado em oncologia médica com formação extensiva na Universidade de Akdeniz, focando-se na imunoterapia para o cancro do rim no Medical Park Antalya.
O Prof. Assoc. Nail Paksoy é especialista em imunoterapia para câncer de rim no Hospital Medipol Bahçelievler, com vasta pesquisa em carcinoma de células renais.
Professor Associado de Oncologia Médica na İstinye University Liv Hospital Topkapı, especializado em imunoterapia para câncer renal.
Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).
She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).
Professor de Oncologia Médica com mais de 20 anos de experiência – O Dr. Cicin é especializado em tratamentos avançados para câncer renal no Hospital Liv da Universidade İstinye Topkapı.
O Prof. Assoc. Atakan Topcu é especializado em terapias-alvo e imunoterapia no Hospital Distrital Medipol Acibadem.
Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.
He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.
Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.
Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).
Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).
Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.
He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.
His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.
He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.
Dr. Tuncay Tas is a urological surgeon at Safe Urology Clinic in Istanbul. He is one of the first five doctors globally to publish results on P-Shot applications. Dr. Tas specializes in urological oncology and male sexual health. He completed his fellowship at Heidelberg University in Germany. His practice focuses on regenerative medicine and robotic surgery for cancer.
Especialista em imunoterapia para câncer de rim – A Dra. Kate apresentou sua pesquisa sobre câncer de pulmão na Conferência Mundial sobre Câncer de Pulmão.
O Dr. Raj Nagarkar realizou mais de 50.000 cirurgias oncológicas com foco na melhoria da qualidade de vida dos pacientes. É especialista em Oncologia Cirúrgica de Mama e Torácica no HCG Manavata Cancer Centre.
O Dr. Shaunak Valame é especialista em imunoterapia para cancro renal, com um forte foco em terapias direcionadas e investigação molecular.
O Dr. Lalit Banswal foca-se em Cirurgias de Cancro Minimamente Invasivas com excelentes resultados no HCG Manavata Cancer Centre.
O Dr. Ahmer Arif Shaikh é especialista em oncologia cirúrgica, com foco em câncer bucal e reabilitação funcional no HCG Manavata Cancer Centre.
Chefe de Ensino no Hospital Regional de Puerto Vallarta, especializado em tratamentos inovadores como imunoterapia para câncer de rim.
Realizou mais de 30.000 exames de PET e atendeu 1.000 pacientes com câncer de tireoide – O Dr. Borde é especialista em terapias avançadas de medicina nuclear no HCG Manavata Cancer Centre.
O Dr. Sridhar P.S. é especialista em radioterapia com ampla formação em oncologia, incluindo imunoterapia para cancro renal no HCG Manavata Cancer Centre.